6 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 6 of 6 clinical reviews.
A complete caregiver guide to administering liraglutide (Saxenda, Victoza) to adolescents aged 12 to 17, covering injection technique, dose escalation, storage, missed doses, and safety monitoring backed by current FDA labeling and clinical trial data.
A guide to liraglutide's effects on growth, puberty, bone density, metabolism, and neurodevelopment in adolescents aged 12 to 17, with trial data, dosing guidance, and safety monitoring protocols.
A guide to off-label liraglutide use in adolescents ages 12 to 17, covering FDA approval status, trial data, dosing, safety, and how it compares to on-label alternatives.
A clinical guide for patients and providers on using liraglutide (Victoza, Saxenda) in adults aged 65+, including dosing adjustments, safety considerations, and how to manage care transitions from geriatric to adult medicine.
A clinical review of off-label liraglutide use in geriatric patients (65+), covering evidence from major trials, age-specific dosing considerations, cardiovascular data, and safety signals unique to older adults.
A guide covering liraglutide use in pediatric patients under age 12, current FDA approval status, dosing evidence, and how to manage the transition to adult endocrinology or obesity medicine care.